Educational guide
Dengue Fever on the Rise: Explore JPT's Dengue Peptide Tools
Dengue Fever on the Rise: Explore JPT's Dengue Peptide Tools Published on 16/07/2024 Dengue on the rise Dengue fever, once considered a tropical disease, it is now spreading beyond subtropical and tropical regions. Belonging to the genus of flavivirdae, this s
This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.
Dengue Fever on the Rise: Explore JPT's Dengue Peptide Tools
Published on 16/07/2024
Dengue on the rise
Dengue fever, once considered a tropical disease, it is now spreading beyond subtropical and tropical regions. Belonging to the genus of flavivirdae, this single positive-stranded RNA virus is primarily transmitted through mosquito bites. With cases increasing 10fold in the last 20 years, Dengue is spreading globally. The WHO estimates half the human population being at risk this year.
Current Treatments
As no specific treatment is available, vector and fever control are the main modes of action. However, recently two Dengue vaccines have been FDA approved and one more currently undergoing trials. As such, monitoring immune responses of new outbreaks, new variant emergences, and immunization efficiencies remains crucial.
JPT's Peptide Tools for Dengue Research
To support your research in understanding and combating Dengue, JPT offers anextensive catalog of peptide products:
PepMix™ Dengue 1 (E) Ultra
PepStar™ Dengue Virus (Capsid protein)
PepStar™ Dengue Virus (Envelope protein)
PepStar™ Dengue Virus (Membrane Glycoprotein)
PepStar™ Dengue Virus (Nonstructural protein 1)
PepStar™ Dengue Virus (Nonstructural protein 3)
PepStar™ Antigen Collection Pan-Flavivirus Ultra (Zika)
Antigen Peptide Dengue Polyprotein - HLA-B*07:02 (APTRVVAAEM)